Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection.

Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD.

J Urol. 1986 May;135(5):920-2.

PMID:
3959241
2.

Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.

Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S.

J Urol. 2002 May;167(5):2007-11.

PMID:
11956428
3.

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.

Lutzeyer W, Rübben H, Dahm H.

J Urol. 1982 Feb;127(2):250-2.

PMID:
7062375
4.
6.
7.

Expectant management of small, recurrent, noninvasive papillary bladder tumors.

Soloway MS, Bruck DS, Kim SS.

J Urol. 2003 Aug;170(2 Pt 1):438-41.

PMID:
12853794
8.

Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.

Jancke G, Damm O, Rosell J, Jahnson S.

Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.

PMID:
18609266
9.

Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.

Brake M, Loertzer H, Horsch R, Keller H.

Urology. 2000 May;55(5):673-8.

PMID:
10792077
11.

Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.

Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.

J Urol. 2000 Jan;163(1):63-7.

PMID:
10604315
13.

Superficial bladder cancer: progression and recurrence.

Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR.

J Urol. 1983 Dec;130(6):1083-6.

PMID:
6644886
14.

TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.

Serretta V, Pavone C, Ingargiola GB, Daricello G, Allegro R, Pavone-Macaluso M.

Eur Urol. 2004 Jun;45(6):730-5; discussion 735-6.

PMID:
15149744
15.

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.

Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.

Urology. 2004 Mar;63(3):466-71.

PMID:
15028439
16.

Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.

Lee SH, Lin JS, Tzai TS, Chow NH, Tong YC, Yang WH, Chang CC, Cheng HL.

Eur Urol. 1996;29(3):266-70; discussion 271.

PMID:
8740029
17.

Changes in grade and stage of recurrent bladder tumors.

Barnes R, Hadley H, Dick A, Johnston O, Dexter J.

J Urol. 1977 Jul;118(1 Pt 2):177-8.

PMID:
875215
18.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989
19.

Management of low grade papillary bladder tumors.

Herr HW, Donat SM, Reuter VE.

J Urol. 2007 Oct;178(4 Pt 1):1201-5; discussion 1205. Epub 2007 Aug 14.

PMID:
17698090
20.

[A clinical study of recurrence and progression of grade 3 superficial bladder tumor].

Ikegami S, Tsuji A, Suzuki S, Sumitomo M, Kimura F, Asano T, Nakajima F, Hayakawa M.

Hinyokika Kiyo. 1999 May;45(5):325-9. Japanese.

PMID:
10410314
Items per page

Supplemental Content

Write to the Help Desk